RxDoctor Payments Data

Michelle Streu, PA

Physician Assistant · Tecumseh, MINPI 1821284951

Payments from drug & device makers

$3,188in general payments, 2019–2025

Across 173 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$618
  • Novo Nordisk$410
  • AbbVie$361
  • Otsuka America Pharmaceutical, Inc.$317
  • AstraZeneca$303
  • Lilly USA, LLC$213
  • plus $966 from 21 others

What the payments were for

  • Food & beverage$3,188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,188 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$2,304
Medicare patients
62
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide17$32,827
OzempicSemaglutide25$29,852
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$27,566
EliquisApixaban28$26,807
FarxigaDapagliflozin Propanediol22$24,890
JardianceEmpagliflozin12$17,818
Atrovent HfaIpratropium Bromide11$5,211
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$4,442
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$4,035
Omeprazole122$2,436
Atorvastatin Calcium196$2,221
Albuterol Sulfate HfaAlbuterol Sulfate50$1,799
Levothyroxine Sodium118$1,318
Gabapentin61$1,099
Ezetimibe11$929

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$213$32,82717 claims
Novo NordiskOzempic$410$29,85225 claims
AstraZenecaFarxiga, Bevespi Aerosphere$303$28,92533 claims
GSKTrelegy Ellipta$165$27,56631 claims
PfizerEliquis$618$26,80728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Tecumseh

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →